Nakajima, A., Seki, M., Taniguchi, S., et al. (2018) Determining an Optimal Clinical Dose of Elobixibat, a Novel Inhibitor of the Ileal Bile Acid Transporter, in Japanese Patients with Chronic Constipation: A Phase II, Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial. Journal of Gastroenterology, 53, 525-534.
https://doi.org/10.1007/s00535-017-1383-5

has been cited by the following article:

• TITLE: The Use of Elobixibat and Lactulose for Bowel Preparation for Colon Capsule Endoscopy

  AUTHORS: Naoki Hotta

  KEYWORDS: Elobixibat, Lactulose, Colon Capsule Endoscopy

  JOURNAL NAME: Open Journal of Medical Imaging, Vol.8 No.4, November 27, 2018

  ABSTRACT: Colon capsule endoscopy was approved for reimbursement under the national health insurance system of Japan in 2014. We decreased quantity of the castor oil and examined an intestinal irrigation degree using Elobixibat and lactulose that could maintain a discharge rate at 100% at a discharge rate and discharge time.